- Home
- LX vs ANGO Comparison
LX vs ANGO Comparison
Compare LX & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
HOLD
Current Price
$12.10
Company Overview
Basic Information| Metric | LX | ANGO |
|---|---|---|
| Founded | 2013 | 1988 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 352.6M | 420.2M |
| IPO Year | 2017 | 2004 |
Fundamental Metrics
Financial Performance| Metric | LX | ANGO |
|---|---|---|
| Price | $2.12 | $12.10 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $3.50 | ★ $18.00 |
| AVG Volume (30 Days) | ★ 1.8M | 273.5K |
| Earning Date | 05-20-2026 | 04-02-2026 |
| Dividend Yield | ★ 18.73% | N/A |
| EPS Growth | N/A | ★ 81.92 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $291,010,000.00 |
| Revenue This Year | N/A | $9.51 |
| Revenue Next Year | $5.74 | $4.96 |
| P/E Ratio | $2.08 | ★ N/A |
| Revenue Growth | N/A | ★ 10.17 |
| 52 Week Low | $1.79 | $8.36 |
| 52 Week High | $7.99 | $13.99 |
Technical Indicators
Market Signals| Indicator | LX | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 49.35 | 59.63 |
| Support Level | $2.03 | $10.45 |
| Resistance Level | $2.40 | $12.72 |
| Average True Range (ATR) | 0.16 | 0.40 |
| MACD | 0.00 | 0.05 |
| Stochastic Oscillator | 29.13 | 74.85 |
Price Performance
Historical Comparison LX
ANGO
About LX LexinFintech Holdings Ltd.
LexinFintech Holdings Ltd is an online consumer finance platform and a technology-driven service provider in China. The group is engaged in online direct sales services and online consumer finance services for its customers in the PRC. Geographically, it derives revenue from China.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.